In this episode of The Open Loop, Chay Carter is joined by Daniel Månsson, Chief Scientific Officer and Founder at Flow Neuroscience.
Daniel shares his journey from clinical psychology and computer science into building one of the most recognised at-home neurostimulation companies for depression.
This is a practical conversation about tDCS, treatment-resistant depression, clinical evidence, and what it takes to bring brain stimulation out of the clinic and into the hands of patients.
We explore why Flow chose transcranial direct current stimulation, how the company built its evidence base across Europe and the UK, and what its FDA approval means for the next stage of growth in the US.
We also discuss the challenge of separating clinically validated neurotechnology from wellness products, the role of doctors in at-home treatment pathways, and how precision psychiatry could shape the next generation of depression care.
Key takeaways:
🔹 Why Flow Neuroscience chose tDCS for at-home depression treatment
🔹 How the company built clinical evidence through real-world data and RCTs
🔹 Why patient access is central to Flow’s approach
🔹 How at-home neurostimulation can balance accessibility with medical oversight
🔹 Why precision psychiatry could help match the right patients to the right treatments
Host: Chay Carter
Founder, Carter Sciences | Co-Founder, Reccy Neuro
LinkedIn: https://www.linkedin.com/in/chay-carter/
Guest: Daniel Månsson
Chief Scientific Officer and Founder at Flow Neuroscience.
LinkedIn: https://www.linkedin.com/in/danielmanss/
Learn more about Flow Neuroscience: https://www.flowneuroscience.com/
Key Chapters:
00:39 Daniel’s Journey from Psychology to Neurotech
04:09 Building Flow Neuroscience for Depression Treatment
07:47 From European Regulation to FDA Approval
11:00 Insights from 60,000 Patients
14:26 Preparing for Flow’s US Launch
18:14 How the Flow tDCS Device Works
21:47 Expanding Indications and Next-Generation Devices
25:32 Balancing Patient Access, Safety, and Medical Oversight
Sponsor:
This episode is sponsored by Reccy Neuro — the home of neurotech. Jobs, companies, investors, events, Cortex industry intelligence, and specialist resources for the neurotech market.
Learn more about Reccy Neuro: https://neuro.reccy.dev/
The Open Loop is a podcast exploring the people, companies, and ideas shaping the future of neurotechnology.
🔔 Subscribe for weekly conversations with the founders, researchers, operators, and industry leaders building what comes next in brain health, medicine, and technology.
If you enjoyed this episode, please subscribe, leave a review, and share it with someone interested in neurotechnology.
New episodes of The Open Loop drop every week.
